ArticleJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews2026
Association of Perioperative Cannabis Use With Postoperative Opioid Consumption in Ankle Fracture Patients.
Article in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe association between cannabinoid use and perioperative pain management is debated. This study evaluates differences in patient characteristics and postoperative outcomes based on self-reported perioperative cannabis use among patients undergoing ankle fracture open reduction and internal fixation (ORIF).
methodsAn IRB-approved study of 259 adults undergoing ankle fracture ORIF (January 2016-December 2022). Data on self-reported cannabis use, demographics, pain management, and postoperative complications were collected. Outcomes included pain (VAS scores), opioid prescription duration, and complication rates. Statistical analysis through chi-square or Fisher exact tests for categorical variables, t-test or Mann-Whitney U test for continuous variables, and a generalized linear model to adjust for confounding.
resultsOf 259 patients, 79 (30.5%) reported perioperative cannabis use. Cannabis users were younger (34.20 years vs. 45.9 years, P = <0.001), predominantly male (P = 0.003), had lower educational attainment (P = 0.011), higher concurrent tobacco use (35.4% vs. 16.1%, P = <0.001), and higher DCI scores (P = 0.010). They demonstrated longer opioid use (4.51 weeks vs. 4.08 weeks, P = 0.014) but no difference in pain scores, dosage, or complications. After adjusting for smoking, sex, and age, cannabis use was not independently associated with opioid duration (Exp[B] = 0.68; 95% CI, 0.24-1.98; P = 0.484). Among cannabis users, 23 patients (29.11%) reported cannabis helpful for postoperative pain relief.
conclusionPerioperative cannabis use was not an independent predictor for postoperative complications or opioid duration. Our findings do not support cannabis as an effective standalone analgesic in this population. Additional research is warranted to assess the effect on orthopaedic trauma care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.